blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1841740

EP1841740 - 3,4,(5)-SUBSTITUTED TETRAHVDROPYRIDINES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  08.07.2011
Database last updated on 02.11.2024
Most recent event   Tooltip08.07.2011Application deemed to be withdrawnpublished on 10.08.2011  [2011/32]
Applicant(s)For:BE  BG  CH  CY  CZ  DE  DK  EE  ES  FI  FR  GB  GR  HU  IE  IS  IT  LI  LT  LU  LV  MC  NL  PL  PT  RO  SE  SI  SK  TR 
Novartis AG
Lichtstrasse 35
4056 Basel / CH
For:AT 
Novartis Pharma GmbH
Brunner Strasse 59
1230 Wien / AT
[N/P]
Former [2009/43]For:BE  BG  CH  CY  CZ  DE  DK  EE  ES  FI  FR  GB  GR  HU  IE  IS  IT  LI  LT  LU  LV  MC  NL  PL  PT  RO  SE  SI  SK  TR 
Novartis AG
Lichtstrasse 35
4056 Basel / CH
For:AT 
Novartis Pharma GmbH
Brunner Strasse 59
1230 Wien / AT
Former [2007/41]For:BE  BG  CH  CY  CZ  DE  DK  EE  ES  FI  FR  GB  GR  HU  IE  IS  IT  LI  LT  LU  LV  MC  NL  PL  PT  RO  SE  SI  SK  TR 
Novartis AG
Lichtstrasse 35
4056 Basel / CH
For:AT 
NOVARTIS-PHARMA GMBH
Brunner Strasse 59
1230 Vienna / AT
Inventor(s)01 / IRIE, Osamu Novartis Pharma K.K
Tsukuba Research Institute, Okubo 8, Tsukuba
Ibaraki 300-2611 / JP
02 / NIHONYANAGI, Atsuko, Novartis Pharma K.K.
Tsukuba Research Institute, Okubo 8, Tsukuba
Ibaraki 300-2611 / JP
03 / TOYAO, Atsushi, Novartis Pharma K.K.
Tsukuba Research Institute, Okubo 8, Tsukkuba
Ibaraki 300-2611 / JP
04 / KANAZAWA, Takanori, Novartis Pharma K.K.
Tsukuba Research Institute, Okubo 8, Tsukuba
Ibaraki 300-2611 / JP
05 / MASUYA, Keiichi
Gemeindeholzweg 30
CH-4103 Bottmingen / CH
 [2007/41]
Representative(s)Dietel-Manske, Anja, et al
Novartis AG
Corporate Intellectual Property
4002 Basel / CH
[N/P]
Former [2007/41]Dietel, Anja, et al
Novartis AG Corporate Intellectual Property
4002 Basel / CH
Application number, filing date06700380.612.01.2006
[2007/41]
WO2006EP00216
Priority number, dateGB2005000078414.01.2005         Original published format: GB 0500784
[2007/41]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006074924
Date:20.07.2006
Language:EN
[2006/29]
Type: A1 Application with search report 
No.:EP1841740
Date:10.10.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 20.07.2006 takes the place of the publication of the European patent application.
[2007/41]
Search report(s)International search report - published on:EP20.07.2006
ClassificationIPC:C07D211/78, C07D401/12, C07D401/10, C07D409/12, A61K31/4545, A61P9/00
[2007/41]
CPC:
C07D401/12 (EP,KR,US); C07D211/72 (KR); A61P1/16 (EP);
A61P13/12 (EP); A61P25/22 (EP); A61P25/28 (EP);
A61P27/06 (EP); A61P3/04 (EP); A61P3/06 (EP);
A61P3/10 (EP); A61P43/00 (EP); A61P9/00 (EP);
A61P9/04 (EP); A61P9/10 (EP); A61P9/12 (EP);
C07D211/78 (EP,US); C07D401/10 (EP,US); C07D409/12 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/41]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:3,4,(5)-SUBSTITUIERTE TETRAHYDROPYRIDINE[2007/41]
English:3,4,(5)-SUBSTITUTED TETRAHVDROPYRIDINES[2007/41]
French:TETRAHYDROPYRIDINES 3,4(,5) SUBSTITUEES[2007/41]
Entry into regional phase14.08.2007National basic fee paid 
14.08.2007Designation fee(s) paid 
14.08.2007Examination fee paid 
Examination procedure04.10.2006Request for preliminary examination filed
International Preliminary Examining Authority: EP
14.08.2007Examination requested  [2007/41]
16.04.2008Despatch of a communication from the examining division (Time limit: M06)
22.10.2008Reply to a communication from the examining division
24.04.2009Despatch of a communication from the examining division (Time limit: M06)
14.10.2009Reply to a communication from the examining division
03.09.2010Communication of intention to grant the patent
14.01.2011Application deemed to be withdrawn, date of legal effect  [2011/32]
22.02.2011Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2011/32]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  16.04.2008
Fees paidRenewal fee
14.01.2008Renewal fee patent year 03
14.01.2009Renewal fee patent year 04
13.01.2010Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.01.201106   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO2004002957  (ACTELION PHARMACEUTICALS LTD [CH], et al) [X] 1-6,11-17 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.